BackBiodesix Overview
Biodesix Inc

Biodesix Target Price

Where could BDSX trade next? Consensus target price: $30.

Get informed when a big investor buys or sells

+ Follow

Share Price

$28.08

Average Target Price

$30.006.9% upside

4 analysts in the last 4 months

High: $35 | Low: $26

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-10Canaccord GenuityKyle Mikson$3524.7% upsideOpen
2026-06-24Roth CapitalMax Masucci$3214% upsideOpen
2026-06-18Canaccord GenuityKyle Mikson$273.8% downsideOpen
2026-06-15H.C. Wainwright$267.4% downsideOpen
2025-09-19Canaccord Genuity$2028.8% downsideOpen
2024-09-16ScotiabankSung Ji Nam$389.3% downsideOpen
2024-07-26Craig-HallumBill Bonello$389.3% downsideOpen

Biodesix (BDSX) FAQ

The latest target price for BDSX is $30. Investors often review this figure alongside Biodesix's historical trend and sector peers before judging valuation or financial health.

Biodesix trades near $28.08 while the consensus target sits at $30 (6.9% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting BDSX's target price ($30), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Biodesix's target price against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.